Wells Fargo Reiterates Equal-Weight Rating on LeMaitre Vascular, Inc. (LMAT)

Market Context

LeMaitre Vascular, Inc. operates in the Healthcare sector. The stock currently trades at $79.00 with a market capitalization of $1.9B. The stock has gained 30.5% over the past 52 weeks.

Analyst coverage from Wells Fargo provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for LeMaitre Vascular, Inc..

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for LeMaitre Vascular, Inc.

Among the 10 most recent ratings: 7 Buy, 3 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Aug 05, 2026	Wells Fargo	Equal-Weight	N/A
Jun 03, 2026	Barrington Research	Outperform	N/A
May 06, 2026	Barrington Research	Outperform	N/A
May 06, 2026	Citizens	Market Outperform	N/A
May 06, 2026	Wells Fargo	Equal-Weight	N/A

Related Tools: Analyst Ratings Dashboard | View LMAT Stock Page